Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9062 |
High Similarity |
NPD6959 |
Discontinued |
0.9012 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8987 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8696 |
High Similarity |
NPD7768 |
Phase 2 |
0.8688 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8616 |
High Similarity |
NPD4380 |
Phase 2 |
0.8562 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD7411 |
Suspended |
0.8554 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8554 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8554 |
High Similarity |
NPD6166 |
Phase 2 |
0.8535 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8535 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8506 |
High Similarity |
NPD1549 |
Phase 2 |
0.8457 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8424 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8395 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8303 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8303 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8303 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8242 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8187 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.815 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8141 |
Intermediate Similarity |
NPD2796 |
Approved |
0.814 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8129 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8121 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8081 |
Intermediate Similarity |
NPD7054 |
Approved |
0.807 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8035 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8025 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8024 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8012 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7989 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7977 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7963 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7963 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7963 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7955 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7955 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7952 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7943 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7922 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7879 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7853 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7845 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7826 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7812 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7797 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7797 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7751 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7688 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7665 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7651 |
Intermediate Similarity |
NPD920 |
Approved |
0.7651 |
Intermediate Similarity |
NPD5403 |
Approved |
0.764 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7636 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7588 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7578 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7568 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7546 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7543 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7541 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7487 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7486 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7486 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7435 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7429 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7416 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD919 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7374 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7358 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7345 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.734 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.734 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD37 |
Approved |
0.7321 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7314 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7306 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7306 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7299 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7289 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7289 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7283 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7267 |
Intermediate Similarity |
NPD943 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7254 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7254 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7243 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7208 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7085 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7049 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7044 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7044 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7024 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7012 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.6995 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6983
|
Remote Similarity |
NPD6746 |
Phase 2 |